Carbohydrate and lipid oxidation in normal and diabetic subjects. 1977

J P Felber, and G Magnenat, and M Casthélaz, and C A Geser, and R Müller-Hess, and N de Kalbermatten, and J R Ebiner, and B Curchod, and P Pittet, and E Jéquier

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010084 Oxidation-Reduction A chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs (Lehninger, Principles of Biochemistry, 1982, p471). Redox,Oxidation Reduction
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D002153 Calorimetry, Indirect Calculation of the energy expenditure in the form of heat production of the whole body or individual organs based on respiratory gas exchange. Calorimetry, Respiration,Calorimetries, Indirect,Calorimetries, Respiration,Indirect Calorimetries,Indirect Calorimetry,Respiration Calorimetries,Respiration Calorimetry
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D003922 Diabetes Mellitus, Type 1 A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence. Diabetes Mellitus, Brittle,Diabetes Mellitus, Insulin-Dependent,Diabetes Mellitus, Juvenile-Onset,Diabetes Mellitus, Ketosis-Prone,Diabetes Mellitus, Sudden-Onset,Diabetes, Autoimmune,IDDM,Autoimmune Diabetes,Diabetes Mellitus, Insulin-Dependent, 1,Diabetes Mellitus, Type I,Insulin-Dependent Diabetes Mellitus 1,Juvenile-Onset Diabetes,Type 1 Diabetes,Type 1 Diabetes Mellitus,Brittle Diabetes Mellitus,Diabetes Mellitus, Insulin Dependent,Diabetes Mellitus, Juvenile Onset,Diabetes Mellitus, Ketosis Prone,Diabetes Mellitus, Sudden Onset,Diabetes, Juvenile-Onset,Diabetes, Type 1,Insulin Dependent Diabetes Mellitus 1,Insulin-Dependent Diabetes Mellitus,Juvenile Onset Diabetes,Juvenile-Onset Diabetes Mellitus,Ketosis-Prone Diabetes Mellitus,Sudden-Onset Diabetes Mellitus
D005230 Fatty Acids, Nonesterified FATTY ACIDS found in the plasma that are complexed with SERUM ALBUMIN for transport. These fatty acids are not in glycerol ester form. Fatty Acids, Free,Free Fatty Acid,Free Fatty Acids,NEFA,Acid, Free Fatty,Acids, Free Fatty,Acids, Nonesterified Fatty,Fatty Acid, Free,Nonesterified Fatty Acids
D005260 Female Females

Related Publications

J P Felber, and G Magnenat, and M Casthélaz, and C A Geser, and R Müller-Hess, and N de Kalbermatten, and J R Ebiner, and B Curchod, and P Pittet, and E Jéquier
February 1979, Clinical science (London, England : 1979),
J P Felber, and G Magnenat, and M Casthélaz, and C A Geser, and R Müller-Hess, and N de Kalbermatten, and J R Ebiner, and B Curchod, and P Pittet, and E Jéquier
January 1988, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas,
J P Felber, and G Magnenat, and M Casthélaz, and C A Geser, and R Müller-Hess, and N de Kalbermatten, and J R Ebiner, and B Curchod, and P Pittet, and E Jéquier
May 1972, Metabolism: clinical and experimental,
J P Felber, and G Magnenat, and M Casthélaz, and C A Geser, and R Müller-Hess, and N de Kalbermatten, and J R Ebiner, and B Curchod, and P Pittet, and E Jéquier
August 1975, Infusionstherapie und klinische Ernahrung,
J P Felber, and G Magnenat, and M Casthélaz, and C A Geser, and R Müller-Hess, and N de Kalbermatten, and J R Ebiner, and B Curchod, and P Pittet, and E Jéquier
September 1976, The Journal of laboratory and clinical medicine,
J P Felber, and G Magnenat, and M Casthélaz, and C A Geser, and R Müller-Hess, and N de Kalbermatten, and J R Ebiner, and B Curchod, and P Pittet, and E Jéquier
January 1956, Metabolism: clinical and experimental,
J P Felber, and G Magnenat, and M Casthélaz, and C A Geser, and R Müller-Hess, and N de Kalbermatten, and J R Ebiner, and B Curchod, and P Pittet, and E Jéquier
May 2009, Biochemical and biophysical research communications,
J P Felber, and G Magnenat, and M Casthélaz, and C A Geser, and R Müller-Hess, and N de Kalbermatten, and J R Ebiner, and B Curchod, and P Pittet, and E Jéquier
May 1979, Minerva medica,
J P Felber, and G Magnenat, and M Casthélaz, and C A Geser, and R Müller-Hess, and N de Kalbermatten, and J R Ebiner, and B Curchod, and P Pittet, and E Jéquier
November 2002, Metabolism: clinical and experimental,
J P Felber, and G Magnenat, and M Casthélaz, and C A Geser, and R Müller-Hess, and N de Kalbermatten, and J R Ebiner, and B Curchod, and P Pittet, and E Jéquier
December 1954, The Journal of biological chemistry,
Copied contents to your clipboard!